Limited effectiveness, weight regain, and high prevalence of adverse events are the three key limitations of semaglutide ...

In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...

Cleveland Clinic experts reveals what's behind "Ozempic face," and list the semaglutide-associated symptoms that can call for medical attention.

New research reveals that semaglutide significantly improves liver health in MASH patients. A new study published in the New ...

The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...

When treating obesity, semaglutide may be associated with a reduced fracture risk compared with sleeve gastrectomy.

For those preferring a drug-free approach to weight loss, research shows that certain nutrients and dietary strategies can ...

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

The benefit was seen as soon as 3 months. Investigators say there should be no delaying treatment for eligible patients.

However, many on Wall Street believe that better days lie ahead for Novo Nordisk. Analysts expect this obesity drug stock to ...

In SELECT, semaglutide was associated with a 41% reduction in major CV events within 6 months — ie, before weight loss or ...

In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release ...